Skip to main content

Grantham, Mayo, Van Otterloo & Co. LLC

SEC CIK
0001352662
Latest filing
Aug 13, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
8,794,077
Value
$798.0M
% of portfolio
1.8%
Quarters held
22
Since Q1 2021
Holdings of ABT by Grantham, Mayo, Van Otterloo & Co. LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,794,077$798.0M1.8%−116,868−1.3%ReducedHolders
Q1 20268,910,945$914.9M2.3%+428,392+5.1%AddedHolders
Q4 20258,482,553$1.06B2.7%+306,069+3.7%AddedHolders
Q3 20258,176,484$1.10B3.1%+361,946+4.6%AddedHolders
Q2 20257,814,538$1.06B3.2%−293,045−3.6%ReducedHolders
Q1 20258,107,583$1.08B3.4%+210,644+2.7%AddedHolders
Q4 20247,896,939$893.2M2.9%+787,251+11.1%AddedHolders
Q3 20247,109,688$810.6M2.5%+1,317,528+22.7%AddedHolders
Q2 20245,792,160$601.9M2.0%+384,152+7.1%AddedHolders
Q1 20245,408,008$614.7M2.2%+1,032,651+23.6%AddedHolders
Q4 20234,375,357$481.6M2.1%+710,501+19.4%AddedHolders
Q3 20233,664,856$354.9M1.7%+801,191+28.0%AddedHolders
Q2 20232,863,665$312.2M1.4%+1,215,172+73.7%AddedHolders
Q1 20231,648,493$166.9M0.8%+13,059+0.8%AddedHolders
Q4 20221,635,434$179.6M1.0%−15,800−1.0%ReducedHolders
Q3 20221,651,234$159.8M0.9%+43,860+2.7%AddedHolders
Q2 20221,607,374$174.6M0.9%−40,129−2.4%ReducedHolders
Q1 20221,647,503$195.0M0.9%−41,277−2.4%ReducedHolders
Q4 20211,688,780$237.7M1.1%−67,118−3.8%ReducedHolders
Q3 20211,755,898$207.4M1.0%+24,686+1.4%AddedHolders
Q2 20211,731,212$200.7M1.0%+6,799+0.4%AddedHolders
Q1 20211,724,413$206.7M1.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.